AU2001266441A1 - Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use - Google Patents
Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical useInfo
- Publication number
- AU2001266441A1 AU2001266441A1 AU2001266441A AU6644101A AU2001266441A1 AU 2001266441 A1 AU2001266441 A1 AU 2001266441A1 AU 2001266441 A AU2001266441 A AU 2001266441A AU 6644101 A AU6644101 A AU 6644101A AU 2001266441 A1 AU2001266441 A1 AU 2001266441A1
- Authority
- AU
- Australia
- Prior art keywords
- hepatocytes
- functional activity
- stimulating
- tetrapeptide
- proposed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention refers to the field of medicine and may be applied as a substance stimulating the functional activity of hepatocytes, restoring the synthesis of non-specific proteins, normalising metabolism activating the processes of proliferation and differentiation of the liver cells. There is proposed a new compound -tetrapeptide lysyl-glutamyl-aspartyl-alanine of the general formula Lys-Glu-Asp-Ala [SEQ ID NO:1]. There is proposed a pharmaceutical composition capable of stimulating the functional activity of hepatocytes and a pharmaceutical peptide substance containing as its active base a therapeutically effective quantity of tetrapeptide of the formula Lys-Glu-Asp-Ala [SEQ ID NO:1] or one of its salts intended for parenteral administration. There is proposed a method of stimulating the functional activity of hepatocytes including therapeutic administration to a patient of the pharmaceutical peptide substance in doses 0.01-100 mug/kg of the body weight at least once a day during a period required for attaining a therapeutic effect.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000125353 | 2000-10-09 | ||
RU2000125353/14A RU2166957C1 (en) | 2000-10-09 | 2000-10-09 | Tetrapeptide stimulating functional activity of hepatocytes, pharmacological agent based on thereof and method of its use |
PCT/RU2001/000199 WO2002030955A2 (en) | 2000-10-09 | 2001-05-15 | Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001266441A1 true AU2001266441A1 (en) | 2002-04-22 |
Family
ID=20240745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001266441A Abandoned AU2001266441A1 (en) | 2000-10-09 | 2001-05-15 | Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
Country Status (8)
Country | Link |
---|---|
US (1) | US7101854B2 (en) |
EP (1) | EP1325026B1 (en) |
AT (1) | ATE273994T1 (en) |
AU (1) | AU2001266441A1 (en) |
CA (1) | CA2425445C (en) |
DE (1) | DE60105042T2 (en) |
RU (1) | RU2166957C1 (en) |
WO (1) | WO2002030955A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2242241C1 (en) * | 2003-12-10 | 2004-12-20 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Tetrapeptide regulating glucose level in diabetes mellitus, pharmacological agent based on thereof and method for its applying |
RU2301678C1 (en) * | 2006-05-30 | 2007-06-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Peptide stimulating regeneration of central nervous system neurons, pharmaceutical composition based on thereof and method for its using |
RU2297239C1 (en) * | 2006-05-30 | 2007-04-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Peptide stimulating regeneration of liver tissue, pharmaceutical composition based on thereof and method for its using |
RU2504389C2 (en) * | 2012-02-16 | 2014-01-20 | Федеральное государственное бюджетное учреждение науки Институт биохимии и физиологии микроорганизмов им. Г.К. Скрябина Российской академии наук (ИБФМ РАН) | METHOD FOR PORE FORMATION IN HEPATOCYTE MEMBRANES BY Bacillus cereus HEMOLYSIN II PROCESSING |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0929575A4 (en) * | 1996-08-23 | 2004-09-08 | Human Genome Sciences Inc | Novel human growth factors |
-
2000
- 2000-10-09 RU RU2000125353/14A patent/RU2166957C1/en active
-
2001
- 2001-05-15 AU AU2001266441A patent/AU2001266441A1/en not_active Abandoned
- 2001-05-15 AT AT01943989T patent/ATE273994T1/en active
- 2001-05-15 WO PCT/RU2001/000199 patent/WO2002030955A2/en active IP Right Grant
- 2001-05-15 CA CA2425445A patent/CA2425445C/en not_active Expired - Fee Related
- 2001-05-15 US US10/398,690 patent/US7101854B2/en not_active Expired - Fee Related
- 2001-05-15 DE DE60105042T patent/DE60105042T2/en not_active Expired - Lifetime
- 2001-05-15 EP EP01943989A patent/EP1325026B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2425445C (en) | 2011-01-18 |
WO2002030955A2 (en) | 2002-04-18 |
US20040009925A1 (en) | 2004-01-15 |
US7101854B2 (en) | 2006-09-05 |
RU2166957C1 (en) | 2001-05-20 |
WO2002030955A3 (en) | 2002-08-15 |
EP1325026A2 (en) | 2003-07-09 |
DE60105042D1 (en) | 2004-09-23 |
ATE273994T1 (en) | 2004-09-15 |
DE60105042T2 (en) | 2005-08-18 |
EP1325026B1 (en) | 2004-08-18 |
CA2425445A1 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2315358T3 (en) | METHOD FOR INCREASING LEPTINE LEVELS USING NICOTINIC ACID COMPOUNDS. | |
IL140412A0 (en) | L-lys -l-glu dipeptides for pharmaceutical preparations | |
IL146432A0 (en) | A tetrapeptide and a pharmaceutical composition containing the same | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
AU2000277238A1 (en) | Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy | |
JPH05505808A (en) | Use of copper(2)-containing compounds to promote wound healing | |
IL149243A0 (en) | Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same | |
GB2316004A (en) | Novel formulations for transdermal delivery of pergolide | |
HK1160778A1 (en) | Pharmaceutical composition comprising an analgesic peptide | |
DE69804974D1 (en) | OPIOID CONJUGATES WITH ENDOGENIC CARRIER PROTEINS | |
IE58805B1 (en) | Use of dipeptide derivatives for the production of medicines for the prevention or treatment of posttraumatic nerve damage after spinal cord and/or brain trauma caused by an accident | |
IL194500A0 (en) | Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application | |
RU2006110623A (en) | AGENT FROM THE SPLEEN OF THE LAND TURTLE STIMULATING HEMOPOESIS IN MAMMALS | |
SK138095A3 (en) | Transdermal therapeutic system for the administration of serotonin agonists | |
AU2001266441A1 (en) | Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use | |
JP2003514025A5 (en) | ||
JP2002530353A5 (en) | ||
ATE513845T1 (en) | PEPTIDE SUBSTANCE WITH IMMUNOGEROPROTECTIVE EFFECT, PHARMACEUTICAL COMPOSITION BASED THEREOF AND METHOD FOR USE | |
CA2264745C (en) | Method of inhibiting biosynthesis of eif5a | |
LT2006024A (en) | Tetrapeptide regulating blood glucose level in diabetes mellitus | |
EP0175440A3 (en) | Method of treating migraine headaches | |
US20070065496A1 (en) | Dermal therapeutic system comprising 2-(3-benzophenyl)propionic acid | |
KR100488038B1 (en) | New bpc peptide salts with organo-protective activity the process for their preparation and their use in therapy | |
JP2002529515A5 (en) | ||
CA2530611A1 (en) | Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |